Heavy Lies the Helmet Episode 131 - TXA: The Clot Thickens
Jul 14, 2025
Discover the compelling world of Tranexamic Acid (TXA), a medication likened to hot sauce for its wide application in trauma care. Delve into the controversies surrounding TXA's use, from its mechanism of action to its critical role in stopping bleeding. Timing is key; learn why administering TXA within the first hour can make all the difference. Explore the unique challenges of pediatric emergency care and hear gripping real-life stories from the ER that highlight the urgent need for effective interventions.
AI Snips
Chapters
Transcript
Episode notes
TXA Use is Controversial
- TXA use is controversial, with some trauma teams against it despite its widespread use in smaller programs.
- Evidence both supports benefits and highlights lack of clear advantage along with potential adverse effects.
How TXA Works
- TXA is an anti-fibrinolytic that stops clot breakdown, not a clot promoter.
- It stabilizes clots rather than causing clots to form or plugging holes.
TXA On-Label and Off-Label Uses
- TXA's FDA approval is limited to dysfunctional uterine bleeding and hemophilia.
- Off-label uses are common despite limited formal indications due to research funding.